Latest News

Key Insights Significant control over Orbia Advance Corporation. de by private companies implies that the general...

It's not a stretch to say that Great Elm Group, Inc.'s ( NASDAQ:GEG ) price-to-sales (or "P/S") ratio of 3.4x right now...

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Lepu Biopharma (SEHK:2157) just ticked off a key milestone, receiving its initial upfront licensing payment from Excalipoint after meeting deal conditions, a concrete step toward monetizing its CTM012 and CTM013 cancer assets. See our latest analysis for Lepu Biopharma. Despite today’s softer mood, with a negative 1 day share price return, Lepu Biopharma’s share price has still logged a triple digit year to date gain, while the 1 year total shareholder return, though strong, lags that surge...

Fresh analyst support, a refinancing break, and a Las Vegas facility deal have put PACS Group (PACS) back in focus, as new compliance and HR leaders step in to guide the next expansion phase. See our latest analysis for PACS Group. The steady stream of positive developments seems to be feeding into sentiment, with PACS Group’s 30 day share price return of around 121% and its roughly 168% year to date share price gain suggesting strong momentum from growth expectations and reduced perceived...

H2O America announced that long-serving leader Eric W. Thornburg will retire as non-executive chair of the board on January 31, 2026, with current CEO Andrew F. Walters set to assume the chair role the next day. This planned handover consolidates board and executive leadership under Walters at a time when the company is emphasizing reliable service and operational performance. We’ll now examine how Andrew Walters taking on both CEO and chair responsibilities could influence H2O America’s...

Penumbra (PEN) has quietly climbed about 11% over the past month and roughly 21% in the past 3 months, drawing fresh attention to whether the current price still leaves upside for long term investors. See our latest analysis for Penumbra. That recent 11.2% one month share price return and 20.99% three month share price return builds on a solid backdrop, with a 27.0% one year total shareholder return suggesting momentum is still leaning in Penumbra’s favor at around $309 per share. If...

Gaztransport & Technigaz (ENXTPA:GTT) has caught investors attention after naming François Michel as its next CEO, effective January 2026. The move restores split governance and sharpens focus on technology driven growth. See our latest analysis for Gaztransport & Technigaz. The appointment of François Michel comes after a choppy stretch, with a 1 month share price return of minus 13.0% even as the year to date share price return is still up 15.2% and the 1 year total shareholder return of...

Enterprise Financial Services (EFSC) has quietly outperformed many regional peers over the past five years, and its recent mix of modest share pullback and solid earnings growth is giving value focused bank investors fresh reasons to revisit the stock. See our latest analysis for Enterprise Financial Services. At around $56 per share, Enterprise Financial Services has given investors a choppy ride recently, with a solid 1 month share price return but softer year to date progress, even as its...

LPL Financial Holdings (LPLA) has quietly held its ground, with the stock roughly flat over the past month after a strong run in the past 3 years and 5 years. See our latest analysis for LPL Financial Holdings. Zooming out, that recent wobble at a share price of $355.72 comes after a solid year to date share price return of 8.45 percent and an even stronger multi year total shareholder return. This suggests momentum is cooling but not broken as investors reassess growth and risk. If LPL’s...

On December 15, 2025, Insperity amended its credit agreement, lifting its revolving credit facility from US$650 million to US$750 million, extending the maturity to December 15, 2028, and easing leverage and EBITDA covenant terms. This expanded and more flexible Facility may give Insperity additional room to fund operations, technology investments, and growth initiatives while managing balance sheet constraints. Next, we’ll examine how the larger revolving facility and relaxed leverage...

Micron Technology reported record fiscal first‑quarter 2026 results for the period ended November 27, 2025, with sales rising to US$13.64 billion and net income reaching US$5.24 billion, and issued guidance for second‑quarter revenue of about US$18.70 billion and diluted EPS near US$8.19, both well above prior expectations. Management highlighted that tight industry supply and AI‑driven demand have already locked in Micron’s entire 2026 high‑bandwidth memory output under price‑and‑volume...

Baldwin Insurance Group (BWIN) just delivered an earnings and financing combo that should catch investors’ attention, topping third quarter profit and revenue expectations while locking in a fresh $600 million term loan. See our latest analysis for Baldwin Insurance Group. Even with today’s upbeat reaction, reflected in a 1 day share price return of 1.92 percent to 22.77 dollars, Baldwin’s 30 day and year to date share price returns remain sharply negative. The 1 year total shareholder return...

NNN REIT (NNN) just lined up a new $300 million senior unsecured term loan facility, giving the company flexible, delayed draw funding it can tap for growth and general corporate needs in a still choppy rate environment. See our latest analysis for NNN REIT. That backdrop helps explain why the stock’s latest share price of $40.68 comes with a modest 1 year to date share price return, but a more solid 1 year total shareholder return of 8.4%. This suggests steady income driven momentum rather...

Steven Madden (SHOO) just delivered a mixed earnings update, with Q3 revenue up about 7% year over year but coming in below Wall Street expectations. Management sounded upbeat about a stronger turn starting in Q4. See our latest analysis for Steven Madden. The earnings miss has not derailed sentiment much, with a roughly 16% 1 month share price return and about 31% over 3 months, while the 3 year total shareholder return near 43% suggests longer term momentum is still intact. If this kind of...

In its Q3 2025 update, Burford Capital reported a more than 50% increase in definitive commitments, 15% portfolio growth year-to-date, and a 61% rise in deployments, while reiterating its aim to double the business by 2030. An interesting angle is management’s indication that more trials and hearings are scheduled over the next 12 months than a year ago, signaling a busier realization pipeline. Next, we’ll explore how Burford’s surging Q3 deployments might influence its long-term investment...

Earlier this year, Lamb Weston reported Q1 2026 results that exceeded analyst expectations, with adjusted EPS of US$0.74 and net sales of US$1.66 billion, supported by 6% volume growth, cost savings, and lower SG&A expenses. Management’s full-year outlook for net sales of US$6.35–US$6.55 billion and adjusted EBITDA of US$1.00–US$1.20 billion signals a focus on stabilizing operations while executing its ‘Focus to Win’ efficiency program. We’ll now examine how this earnings beat and reaffirmed...

In December 2025, several United Therapeutics insiders, including officer Paul A. Mahon and directors Jan Malcolm and Christopher Patusky, disclosed past sales of company stock totaling more than US$5.33 million, as required under federal securities laws. These insider transactions came as analysts highlighted encouraging clinical progress, including the first clinical xenotransplantation in the EXPAND study, alongside a solid operational backdrop for United Therapeutics. We’ll explore how...

Earlier in December 2025, The Hershey Company’s board amended its bylaws to reinforce independent board leadership and clarify emergency governance procedures, while JAKKS Pacific announced a new Hershey-branded “Charming” collectibles line launching at CVS on December 26, 2025. At the same time, Morgan Stanley highlighted easing cocoa cost pressures and a potential multiyear margin recovery as key reasons for upgrading its view on Hershey’s earnings outlook. Next, we’ll assess how...

Universal (UVV) just locked in a new $1.4 billion senior unsecured credit facility, expanding its prior $1.15 billion line. This move meaningfully boosts financial flexibility for operations and future growth. See our latest analysis for Universal. The stock has been quietly grinding higher, with a recent 7 day share price return of 3.09 percent and a solid 5 year total shareholder return of 53.03 percent. This suggests steady, not explosive, momentum as this new credit facility deepens...

DFI Retail Group Holdings (SGX:D01) has just laid out a new three year roadmap, pairing double digit underlying profit growth targets with a higher 70% dividend payout ratio. This combination directly shapes the stock’s appeal. See our latest analysis for DFI Retail Group Holdings. The new roadmap lands after a powerful re-rating, with a roughly 76% year to date share price return and a 1 year total shareholder return of about 109%, signalling that momentum is firmly rebuilding after years of...

Sally Beauty Holdings (SBH) just delivered an earnings update that quietly checks a lot of investor boxes. Revenue grew 1.3% year over year, topping expectations, while EBITDA and EPS also came in ahead of forecasts. See our latest analysis for Sally Beauty Holdings. The solid earnings beat fits into a broader recovery story, with a 41.1% year to date share price return and a 24.34% one year total shareholder return suggesting momentum is building as investors reassess execution risk. If this...

Birkenstock Holding (NYSE:BIRK) just delivered a full year earnings update that topped expectations, with stronger sales and a big jump in profit putting fresh attention on what investors are really paying for this growth. See our latest analysis for Birkenstock Holding. Those numbers appear to be shifting sentiment, with the share price now at $46.4 and a strong 1 month share price return of 17.41% contrasting with a weaker 1 year total shareholder return of 18.82% in the red. This suggests...